Histopathologic and immunologic effects of the itraconazole treatment in a murine model of chronic pulmonary paracoccidioidomycosis

Tonny W. Naranjo, Damaris E. Lopera, Lucy R. Diaz-Granados, Jhon J. Duque, Angela Restrepo, Luz E. Cano

    Research output: Contribution to journalArticle in an indexed scientific journalpeer-review

    13 Scopus citations


    A comparative study, based on histopathologic findings (inflammation, cellularity, and fibrosis) and immunologic parameters (pro-inflammatory and anti-inflammatory cytokines), was carried out in order to evaluate the effects of itraconazole (ITC) treatment and its starting time in a BALB/c murine model of chronic pulmonary paracoccidioidomycosis (PCM), induced by intranasal inoculation of Paracoccidioides brasiliensis (Pb) conidia. Two different groups of mice were exposed to ITC therapy beginning at the 4th or 8th week after Pb infection, respectively. ITC was administered daily, via gavage, for a period of sixty days. At weeks 0, 4, 8, 12 and 16 the animals were sacrificed and their lungs removed for histology staining with hematoxylin and eosin (H&E), Masson's trichromic and Gomori-Grocott; pulmonary levels of IL-1β, TNF-α, IFN-γ, IL-13 and TGF-β were also measured by ELISA. The development or absence of the principal pulmonary PCM sequela, lung fibrosis, was directly related to the therapy's starting time. This and other histopathologic findings were related to the behavior of cytokine levels.

    Original languageEnglish
    Pages (from-to)1153-1162
    Number of pages10
    JournalMicrobes and Infection
    Issue number14-15
    StatePublished - Dec 2010

    Bibliographical note

    Funding Information:
    This work was supported by COLCIENCIAS (project No. 2213-04-16439 ), Bogotá, Colombia, by the Corporación para Investigaciones Biológicas (CIB) and by the University of Antioquia (UdeA) , Medellín, Colombia.


    • Cytokines
    • Itraconazole
    • Lung fibrosis
    • Paracoccidioidomycosis


    Dive into the research topics of 'Histopathologic and immunologic effects of the itraconazole treatment in a murine model of chronic pulmonary paracoccidioidomycosis'. Together they form a unique fingerprint.

    Cite this